Capital International, Inc. Guardant Health, Inc. Transaction History

Capital International, Inc.

$7.57 Billion
Q3 2024

A detailed history of Capital International, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Capital International, Inc. holds 11,858 shares of GH stock, worth $387,163. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,858

Previous 11,858 -0.0%

Holding current value

$387,163

Previous $342,000 20.76%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$20.94 - $38.01 $15,830 - $28,735	-756 Reduced 5.99%	11,858 $424,000
Q4 2022 Feb 14, 2023	SELL	$25.44 - $59.78 $482,469 - $1.13 Million	-18,965 Reduced 60.06%	12,614 $343,000
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $828,011 - $1.16 Million	18,965 Added 150.35%	31,579 $1.7 Million
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $937,687 - $2.52 Million	-32,536 Reduced 72.06%	12,614 $509,000
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $778,369 - $1.62 Million	16,132 Added 55.59%	45,150 $2.99 Million
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $61,298 - $83,217	-691 Reduced 2.33%	29,018 $2.9 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $51,557 - $68,992	-522 Reduced 1.73%	29,709 $3.71 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $380,792 - $574,743	3,469 Added 12.96%	30,231 $3.75 Million
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $138,473 - $195,219	-1,090 Reduced 3.91%	26,762 $4.09 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $2.78 Million - $3.79 Million	27,852 New	27,852 $3.59 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.

Account

Capital International, Inc. Guardant Health, Inc. Transaction History